Immunocore reports first quarter financial results and provides a business update
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Recommendation of “Hold” by Brokerages
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
Here Are Monday’s Top Wall Street Analyst Research Calls: Alnylam Pharmaceuticals, Circle Internet, Fifth Third Bancorp, Intuit, ServiceNow, Qualcomm, Trade Desk, and More
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Recommendation of “Moderate Buy” from Analysts
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
Immunocore (IMCR) Upgraded to Strong Buy: Here's Why
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Consensus Rating of “Moderate Buy” from Brokerages
Immunocore announces R&D leadership evolution
Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock?
Immunocore Holdings plc (IMCR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should Know
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of “Moderate Buy” by Brokerages
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Average Rating of “Moderate Buy” by Brokerages
Immunocore to present at upcoming investor conferences
Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver Meeting
Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to Say
Immunocore reports third quarter financial results and provides a business update
Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Immunocore Holdings Plc (IMCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript
Immunocore (IMCR) Q2 Revenue Jumps 30%
Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics
Immunocore reports second quarter financial results and provides a business update
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
Is it a Good Idea to Invest in Immunocore Stock Right Now?
Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
New Strong Buy Stocks for May 8th
Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics
Immunocore reports first quarter financial results and provides a business update
Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet
Immunocore to present at upcoming investor conferences
Insiders Make Huge Purchases of These 4 Biotech Stocks
Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
Immunocore to present at upcoming investor conferences